Krüger Stefan, Ewig Santiago, Giersdorf Sven, Hartmann Oliver, Frechen Dirk, Rohde Gernot, Suttorp Norbert, Welte Tobias
Medical Clinic I, Medical Faculty, RWTH University Aachen, Germany.
Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, Ev. Krankenhaus Herne und Augusta Kranken-Anstalt Bochum, Germany.
Respir Med. 2014 Nov;108(11):1696-705. doi: 10.1016/j.rmed.2014.09.014. Epub 2014 Oct 2.
Dysnatremia is a frequent finding in patients with community acquired pneumonia (CAP) and a predictor of mortality. We studied the relation between dysnatremia, comorbidities and CT-pro-AVP and MR-proANP.
We enrolled 2138 patients (60 ± 18 years, 55% male) with CAP from the CAPNETZ database. Pro-atrial natriuretic peptide (proANP), pro-vasopressin (proAVP), serum sodium and CRB-65 score were determined on admission. Patients were followed up for 28 days. Sodium concentration on admission was examined as a function of mortality at 28 days. Hyponatremia (HypoN) was defined as admission serum sodium <136 mmol/L, hypernatremia (HyperN) as admission serum sodium >145 mmol/L.
HypoN was diagnosed in 680 (31.8%) patients, HyperN in 29 (1.4%) patients. Comorbidities were associated with sodium levels, and CT-pro-AVP and MR-proANP were inversely related to sodium levels. Patients with HypoN were older, had a higher CRB-65 score and higher values of CT-proAVP and MR-proANP (all p < 0.05). When examined as a function of sodium values, a U-shaped association was found between sodium levels and 28 day mortality. In multivariate Cox proportional hazards analysis, HypoN and HyperN were independent predictors of 28 day mortality. Sodium levels added to the predictive potential of proAVP and proANP.
HypoN is common at admission among CAP patients and is independently associated with mortality. HyperN is rare at admission among CAP patients but is also independently associated with mortality. The combination of sodium and CT-pro-AVP and MR-proANP levels achieved the highest prediction of mortality.
低钠血症是社区获得性肺炎(CAP)患者常见的表现,也是死亡率的预测指标。我们研究了低钠血症、合并症与C末端前体血管加压素(CT-pro-AVP)和中段前体心钠素(MR-proANP)之间的关系。
我们从CAPNETZ数据库中纳入了2138例CAP患者(年龄60±18岁,男性占55%)。入院时测定前体心钠素(proANP)、前体血管加压素(proAVP)、血清钠和CRB-65评分。对患者进行28天的随访。将入院时的钠浓度作为28天死亡率的函数进行研究。低钠血症(HypoN)定义为入院时血清钠<136 mmol/L,高钠血症(HyperN)定义为入院时血清钠>145 mmol/L。
680例(31.8%)患者诊断为低钠血症,29例(1.4%)患者诊断为高钠血症。合并症与钠水平相关,CT-pro-AVP和MR-proANP与钠水平呈负相关。低钠血症患者年龄较大,CRB-65评分较高,CT-proAVP和MR-proANP值较高(所有p<0.05)。当作为钠值的函数进行研究时,发现钠水平与28天死亡率之间呈U形关联。在多变量Cox比例风险分析中,低钠血症和高钠血症是28天死亡率的独立预测因素。钠水平增加了proAVP和proANP的预测潜力。
CAP患者入院时低钠血症常见,且与死亡率独立相关。CAP患者入院时高钠血症罕见,但也与死亡率独立相关。钠与CT-pro-AVP和MR-proANP水平的联合使用对死亡率的预测效果最佳。